loading page

The feasibility evaluation of transapical saddle-shaped valved stent for transcatheter mitral valve implantation
  • +6
  • Kaiqin Wu,
  • Shaorui Gu,
  • Tiancheng Lu,
  • Shengting Dong,
  • Chenglai Dong,
  • Haitao Huang,
  • Zhenchuan Liu,
  • Xin Zhang,
  • Yongxin Zhou
Kaiqin Wu
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China

Corresponding Author:kailchin@163.com

Author Profile
Shaorui Gu
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile
Tiancheng Lu
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile
Shengting Dong
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile
Chenglai Dong
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile
Haitao Huang
Department of Thoracic and Cardiovascular Surgery Nantong First People's Hospital Nantong 226001 China
Author Profile
Zhenchuan Liu
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile
Xin Zhang
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile
Yongxin Zhou
Department of Thoracic-Cardiovascular Surgery Tongji Hospital School of Medicine Tongji University Shanghai 200065 China
Author Profile

Abstract

Background: Transcatheter mitral valve implantation (TMVI) is a promising and minimally invasive treatment for high-risk mitral regurgitation (MR). The purpose of this study was to investigate the feasibility of a novel self-expanding valved stent for transcatheter mitral valve implantation via apical access. Methods: A novel self-expanding mitral valved stent system was designed and fabricated for the in vivo evaluation. It is consists of an atrial flange and a saddle-shaped ventricular body connected by two opposing anchors and two opposing extensions. During the valve deployment, each anchor is controlled by a recurrent string. TMVI was performed in ten pigs using the valve prosthesis through the apical access to verify technical feasibility. Echocardiography and ventricular angiography were used to assess hemodynamic data and valve function. The surviving pigs were sacrificed four weeks later to confirm stent deployment. Results: Ten animals underwent transapical mitral valve implantation with the novel mitral valved stent. Optimal valve deployment and accurate anatomical adjustment were obtained in nine animals. Implantation failed in one case, and the animal died one day later due to stent mismatch. After stent implantation, the hemodynamic parameter of other animals was stable and valve function was normal. The mean pressure across the mitral valve and left ventricular outflow tract (LVOT) were 2.98±0.91mmHg and 3.42±0.66 mmHg, respectively. The macroscopic evaluation confirmed the stable and secure positioning of the stents in the mitral valve. No obvious valve displacement, embolism, and paravalvular leakage were observed four weeks after valve implantation. Conclusions: This study proved that the novel mitral valved valve stent is technically feasible in animals. This device features opposing anchors, opposing recurrent strings, and saddle-like ventricular portions, providing structural design details for reducing TMVI complications. However, the long-term feasibility and durability of this valved stent need to be improved and verified.
15 Dec 2021Submitted to Journal of Cardiac Surgery
15 Dec 2021Submission Checks Completed
15 Dec 2021Assigned to Editor
29 Dec 2021Reviewer(s) Assigned
24 Jan 2022Review(s) Completed, Editorial Evaluation Pending
24 Jan 2022Editorial Decision: Revise Major
28 Jan 20221st Revision Received
31 Jan 2022Submission Checks Completed
31 Jan 2022Assigned to Editor
31 Jan 2022Reviewer(s) Assigned
14 Feb 2022Review(s) Completed, Editorial Evaluation Pending
14 Feb 2022Editorial Decision: Accept
Jun 2022Published in Journal of Cardiac Surgery volume 37 issue 6 on pages 1537-1543. 10.1111/jocs.16426